Trump unveils deal for AstraZeneca to cut Medicaid drug prices and join “TrumpRx” site
Pharmaceutical giant AstraZeneca will offer U.S. patients discounted prices for some prescription drugs, President Trump announced Friday, the second major drug company to strike a deal with the Trump administration in recent weeks. Under the deal, AstraZeneca will offer its drugs to Medicaid patients at “most-favored-nation” prices, meaning the U.K.-based drugmaker will charge no more